GlassScriptPhysician profile
Mohan S Vodapally
NPI 1952340887
$26,392.56
in general payments reported to CMS, 2019-2025
47 companies · $2,110 in 2025
The $2,110 reported for 2025 was more than what 79% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,621 · 2020: $2,079 · 2021: $3,749 · 2022: $5,434 · 2023: $5,058 · 2024: $3,342 · 2025: $2,110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,746 · Travel and Lodging: $2,764.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,745.81 |
| Travel and Lodging | $2,763.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $4,909.74 | 2023-2025 | Evoke Scs, Evoke |
| Boston Scientific Corporation | $2,087.87 | 2019-2024 | Wavewriter Alpha Prime 16, Intracept |
| Abbvie INC. | $1,913.32 | 2021-2025 | Ubrelvy, Qulipta, Botox |
| Medtronic, INC. | $1,821.86 | 2021-2025 | Intellis Adaptivestim, Accurian, Inceptiv |
| Collegium Pharmaceutical, INC. | $1,451.23 | 2019-2025 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,365.44 | 2019-2025 | Relistor |
| Scilex Pharmaceuticals INC. | $1,360.60 | 2019-2025 | Ztlido |
| Medtronic USA, INC. | $1,345.50 | 2019-2020 | |
| Vertiflex, INC. | $1,236.55 | 2019 | |
| Relievant Medsystems, INC. | $1,201.07 | 2021-2023 | Intracept |
| Aurora Spine, INC. | $1,105.70 | 2022 | |
| Spinal Simplicity, LLC | $964.88 | 2022-2024 | Ha Minuteman G3-R |
| Abbott Laboratories | $722.14 | 2020-2024 | Proclaim, Eterna |
| Tersera Therapeutics LLC | $633.21 | 2019-2025 | Prialt |
| Spr Therapeutics, INC | $552.07 | 2020-2025 | Sprint Pns System |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohan Vodapally listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.